Nazy Zomorodian

Islamic Azad University, Karaj — IR

Medicine · Health Sciences

15h-index1.7kcitations52works3.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(29), Renal and related cancers(22), Bladder and Urothelial Cancer Treatments(11), Prostate Cancer Treatment and Research(8), Cancer Genomics and Diagnostics(8)

Publications52 total

Advances in Radiotherapy and Chemoradiotherapy for the Treatment of Gastric Cancer (2014-2023): A Scientometric Approach
Medical Journal of the Islamic Republic of Iran·2025Open Access
PD-1 blockade plus cisplatin-based chemotherapy in patients with small cell/neuroendocrine bladder and prostate cancers
Cell Reports Medicine·2024· 8 citedOpen Access
Talazoparib Plus Enzalutamide in Patients With HRR-Deficient mCRPC: Practical Implementation Steps for Oncology Nurses and Advanced Practice Providers
Clinical journal of oncology nursing·2024· 1 cited
Updated results of a phase Ib single-center study of pembrolizumab in combination with chemotherapy in patients with locally advanced or metastatic small cell/neuroendocrine cancers of the prostate and urothelium.
Journal of Clinical Oncology·2023· 9 cited
Interim results of a phase Ib single-center study of pembrolizumab in combination with chemotherapy in patients with locally advanced or metastatic small cell/neuroendocrine cancers of the prostate and urothelium.
Journal of Clinical Oncology·2022· 1 cited
A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma
Journal of Immunotherapy·2020· 20 cited
The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells
Prostate Cancer and Prostatic Diseases·2020· 21 citedOpen Access
Phase 1 Trial of Stereotactic Body Radiation Therapy Neoadjuvant to Radical Prostatectomy for Patients With High-Risk Prostate Cancer
International Journal of Radiation Oncology*Biology*Physics·2020· 16 citedOpen Access
Phase I Trial of Stereotactic Body Radiotherapy Neoadjuvant to Radical Prostatectomy for Patients with Unfavorable and High-Risk Non-Metastatic Prostate Cancer: Feasibility And Safety
International Journal of Radiation Oncology*Biology*Physics·2019
MP34-03 AN OPEN-LABEL, NEOADJUVANT PHASE 2 CLINICAL TRIAL COMPARING THE EFFECTS OF AR INHIBITION WITH AND WITHOUT SRC OR MEK INHIBITION ON THE DEVELOPMENT OF EMT IN PROSTATE CANCER: AN OUTCOME REPORT
The Journal of Urology·2019Open Access
A phase I, open-label, dose-escalation and cohort expansion study evaluating the safety and immune response to autologous dendritic cells transduced with AdGMCA9 in patients with metastatic renal cell carcinoma.
Journal of Clinical Oncology·2018· 1 cited
An open-label phase II clinical trial of the RXR agonist IRX4204 in taxane-resistant, castration-resistant metastatic prostate cancer (CRPC).
Journal of Clinical Oncology·2014· 5 cited
A phase I, open label, dose escalation and cohort expansion study to evaluate the safety and immune response to autologous dendritic cells (DC) transduced with AdGMCA9 (DC-AdGMCAIX) in patients with mRCC.
Journal of Clinical Oncology·2014· 2 cited
An open-label phase II clinical trial of the RXR agonist IRX4204 in taxane-resistant, castration-resistant metastatic prostate cancer (CRPC).
Journal of Clinical Oncology·2014· 5 cited
Salvage-Targeted Kidney Cancer Therapy in Patients Progressing on High-Dose Interleukin-2 Immunotherapy
The Cancer Journal·2013· 12 cited
572 CLINICAL, MOLECULAR AND GENETIC CORRELATES OF LYMPHATIC SPREAD IN CLEAR CELL RENAL CELL CARCINOMA
The Journal of Urology·2012
Clinical, Molecular, and Genetic Correlates of Lymphatic Spread in Clear Cell Renal Cell Carcinoma
European Urology·2012· 31 cited
Prognostic Value of Microvascular Invasion in Predicting the Cancer Specific Survival and Risk of Metastatic Disease in Renal Cell Carcinoma: A Multicenter Investigation
The Journal of Urology·2011· 49 cited
Smoking negatively impacts renal cell carcinoma overall and cancer‐specific survival
Cancer·2011· 52 cited
The effect of tobacco exposure in renal cell carcinoma (RCC) overall and cancer-specific survival.
Journal of Clinical Oncology·2011
page 1 of 3Next →

Frequent Co-authors

Allan J. Pantuck(39), Arie S. Belldegrun(39), Fairooz F. Kabbinavar(32), Tobias Klatte(29), Brian Shuch(11), David B. Seligson(10), Stephen B. Riggs(10), Matthew B. Rettig(10), Jonathan Said(9), John T. Leppert(8), Edward N. Rampersaud(7), Michela de Martino(6), Nagesh Rao(6), Nils Kroeger(6), Priya Rao(5), Frédéric D. Birkhäuser(4), Robert E. Reiter(4), Ankush Sachdeva(4), Alexandra Drakaki(4), Sandy Liu(4)